July 13, 2009 – Boston Scientific today announced CE mark for its LATITUDE Patient Management system, used to remotely monitor patients with implantable cardiac devices.
The system gathers information on both the device and a patient's heart health status, detects clinical events between scheduled physician visits and sends relevant data directly to the physician, enabling him or her to see changes in their patients' cardiac health sooner than follow-up visits.
LATITUDE is the only remote cardiac device monitoring system to offer a wireless weight scale and blood pressure monitor, both of which are recommended by the European Society of Cardiology for the management of class I heart failure patients.
It will be launched in Europe in a phased approach beginning this week.
"The wireless LATITUDE system will enable me to more closely monitor my patients while helping manage hospital workflow," said Konstantin M. Heinroth, M.D., department of medicine, Martin Luther University Halle-Wittenberg, Halle, Germany. "I hope to provide my patients added convenience and the peace of mind that comes from knowing both their device and heart health status can be monitored."
Boston Scientific has enrolled more than 130,000 patients on the LATITUDE system since its introduction in the U.S. in 2006, which the company said makes it the most rapidly adopted remote cardiac device monitoring system in the industry.
The international version of the LATITUDE system is compatible with the company's wireless TELIGEN implantable cardioverter defibrillator (ICD) and COGNIS cardiac resynchronization therapy defibrillator (CRT-D).
For more information: www.bostonscientific.com
July 10, 2024 
